Literature DB >> 1360257

Dose-dependent effects of 6-hydroxy dopamine on deprivation myopia, electroretinograms, and dopaminergic amacrine cells in chickens.

X X Li1, F Schaeffel, K Kohler, E Zrenner.   

Abstract

We found that a single intravitreal injection of 6-hydroxy dopamine (6-OHDA) is highly efficient in blocking the development of deprivation-induced myopia in young chickens. To investigate the effects of 6-OHDA on retinal function, we studied electroretinograms (ERGs) in chickens aged 15-25 days, 4 days subsequent to the injection. Both spectral sensitivity and oscillatory potentials were tested. In addition, a histological examination was performed of dopaminergic amacrine cells labeled by a monoclonal antibody against tyrosine hydroxylase. We found that, at doses of 6-OHDA sufficient to suppress deprivation myopia entirely, no effect could be detected on either the ERGs or on the density and appearance of dopaminergic amacrine cells. For higher doses, spectral sensitivity and the number of dopaminergic amacrine cells declined gradually. In contrast, as doses increased, oscillatory potentials 1 and 2 grew in amplitude only to decline at the highest doses. The results indicate that (1) development of deprivation myopia requires normal retinal function and that (2) slight changes in the gains of dopaminergic pathways are sufficient to block the development of deprivation myopia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360257     DOI: 10.1017/s0952523800011287

Source DB:  PubMed          Journal:  Vis Neurosci        ISSN: 0952-5238            Impact factor:   3.241


  16 in total

1.  Studies on retinal mechanisms possibly related to myopia inhibition by atropine in the chicken.

Authors:  Ute Mathis; Marita Feldkaemper; Min Wang; Frank Schaeffel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-26       Impact factor: 3.117

2.  Inhibition of form-deprivation myopia by a GABAAOr receptor antagonist, (1,2,5,6-tetrahydropyridin-4-yl) methylphosphinic acid (TPMPA), in guinea pigs.

Authors:  Zhen-Ying Cheng; Xu-Ping Wang; Katrina L Schmid; Xu-Guang Han
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-15       Impact factor: 3.117

3.  Retinal dysfunction and refractive errors: an electrophysiological study of children.

Authors:  D I Flitcroft; G G W Adams; A G Robson; G E Holder
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

Review 4.  IMI - Report on Experimental Models of Emmetropization and Myopia.

Authors:  David Troilo; Earl L Smith; Debora L Nickla; Regan Ashby; Andrei V Tkatchenko; Lisa A Ostrin; Timothy J Gawne; Machelle T Pardue; Jody A Summers; Chea-Su Kee; Falk Schroedl; Siegfried Wahl; Lyndon Jones
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-02-28       Impact factor: 4.799

5.  Pharmaceutical intervention for myopia control.

Authors:  Prema Ganesan; Christine F Wildsoet
Journal:  Expert Rev Ophthalmol       Date:  2010-12-01

Review 6.  Dopamine signaling and myopia development: What are the key challenges.

Authors:  Xiangtian Zhou; Machelle T Pardue; P Michael Iuvone; Jia Qu
Journal:  Prog Retin Eye Res       Date:  2017-06-07       Impact factor: 21.198

Review 7.  Dopamine and retinal function.

Authors:  Paul Witkovsky
Journal:  Doc Ophthalmol       Date:  2004-01       Impact factor: 2.379

Review 8.  Retinal-image mediated ocular growth as a mechanism for juvenile onset myopia and for emmetropization. A literature review.

Authors:  D A Goss; M G Wickham
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

9.  High susceptibility to experimental myopia in a mouse model with a retinal on pathway defect.

Authors:  Machelle T Pardue; Amanda E Faulkner; Alcides Fernandes; Hang Yin; Frank Schaeffel; Robert W Williams; Nikita Pozdeyev; P Michael Iuvone
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-02       Impact factor: 4.799

Review 10.  The multifunctional choroid.

Authors:  Debora L Nickla; Josh Wallman
Journal:  Prog Retin Eye Res       Date:  2009-12-29       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.